KLF4 and ovarian cancer: When we determined the ratio KLF4α/KLF4(FL) in all these clinical samples, we noticed an appreciable increase of the ratio in 4/5 breast, 3/5 kidney, 3/5 lung, and 5/5 ovary cancer samples compared to their corresponding healthy tissues (Figure 2A bottom panels).